These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Nilsson B; Korsgren O; Lambris JD; Ekdahl KN Trends Immunol; 2010 Jan; 31(1):32-8. PubMed ID: 19836998 [TBL] [Abstract][Full Text] [Related]
8. Complement inhibition in biomaterial- and biosurface-induced thromboinflammation. Ekdahl KN; Huang S; Nilsson B; Teramura Y Semin Immunol; 2016 Jun; 28(3):268-77. PubMed ID: 27211838 [TBL] [Abstract][Full Text] [Related]
9. Effect of oxide layer modification of CoCr stent alloys on blood activation and endothelial behavior. Milleret V; Ziogas A; Buzzi S; Heuberger R; Zucker A; Ehrbar M J Biomed Mater Res B Appl Biomater; 2015 Apr; 103(3):629-40. PubMed ID: 24964763 [TBL] [Abstract][Full Text] [Related]
10. The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies. Nilsson B; Teramura Y; Ekdahl KN Mol Immunol; 2014 Oct; 61(2):185-90. PubMed ID: 24998801 [TBL] [Abstract][Full Text] [Related]
11. Validation of an MPC Polymer Coating to Attenuate Surface-Induced Crosstalk between the Complement and Coagulation Systems in Whole Blood in In Vitro and In Vivo Models. Asif S; Asawa K; Inoue Y; Ishihara K; Lindell B; Holmgren R; Nilsson B; Rydén A; Jensen-Waern M; Teramura Y; Ekdahl KN Macromol Biosci; 2019 May; 19(5):e1800485. PubMed ID: 30786149 [TBL] [Abstract][Full Text] [Related]
12. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Jackson SP; Darbousset R; Schoenwaelder SM Blood; 2019 Feb; 133(9):906-918. PubMed ID: 30642917 [TBL] [Abstract][Full Text] [Related]